1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Analytical Tool - Protein Kinase Inhibitors in Oncology

Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2014*

The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies active in the development of PKIs in oncology
* Information on key industry related PKI drug projects in oncology
* Data from most important clinical trials
* Information on early developmental stage projects
* Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners & competitors
* Laying down a comprehensive framework for further analysis of the field
* Producing presentations surrounding the development of PKI drugs in oncology
* Identifying emerging PKI cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of PKI drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Protein Kinase Inhibitors in Oncology

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • April 2016
  • by Global Data

PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023 Summary Renal cell carcinoma (RCC) is among the 10 most frequently occurring cancers in Western countries. The RCC market ...

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion ...

COPD: KOL Insight

COPD: KOL Insight

  • $ 8 085
  • Industry report
  • April 2016
  • by Firstword Pharma

Is the COPD treatment market poised for a fundamental shift? After years of dominance by a handful of brands, change is in the air for COPD treatment. Will deep set preferences finally be overturned, ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective and Analgesic Market in Switzerland

  • July 2016
    13 pages
  • Anti-Infective  

    Analgesic  

    Diabetes  

  • Switzerland  

View report >

Therapy Market in the US

  • July 2016
    5 pages
  • Vaccine  

    Infectious Dise...  

  • United States  

View report >

Global Anti-Infective Market

  • July 2016
    10 pages
  • Anti-Infective  

  • Colombia  

    United States  

    Europe  

View report >

Related Market Segments :

Therapy

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.